FILE PHOTO: The logo of Lupin, India's No. 2 drugmaker, is seen on the facade of its pharmaceutical plant in Verna FILE PHOTO: The logo of Lupin, India's No. 2 drugmaker, is seen on the facade of its ...
Feb 10 (Reuters) - Indian drugmaker Lupin said on Tuesday it has settled a patent infringement dispute with Japan's Astellas Pharma over the bladder disorder drug Mirabegron, allowing it to continue ...
Under the terms of the separate settlement agreements with Lupin and Zydus, Astellas will receive a total of $60 million to resolve the litigations from the two companies. In addition, Astellas will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results